These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2581392)

  • 21. A tetraantennary glycopeptide from human Tamm-Horsfall glycoprotein inhibits agglutination of desialylated erythrocytes induced by leucoagglutinin.
    Serafini-Cessi F; Malagolini N; Dall'Olio F
    Biosci Rep; 1984 Nov; 4(11):973-8. PubMed ID: 6525453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyacrylamides bearing pendant alpha-sialoside groups strongly inhibit agglutination of erythrocytes by influenza A virus: multivalency and steric stabilization of particulate biological systems.
    Lees WJ; Spaltenstein A; Kingery-Wood JE; Whitesides GM
    J Med Chem; 1994 Sep; 37(20):3419-33. PubMed ID: 7932570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase.
    Basak S; Tomana M; Compans RW
    Virus Res; 1985 Feb; 2(1):61-8. PubMed ID: 3984493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human placental alkaline phosphatase, an inhibitor of hemagglutination by PR8-influenza A virus.
    Ghosh NK; Rukenstein A; Labowsky C; Cox RP
    Experientia; 1974 Apr; 30(4):333-5. PubMed ID: 4837607
    [No Abstract]   [Full Text] [Related]  

  • 25. [Difference in the spectrum of erythrocyte hemagglutination and elution rate in influenza A viruses of different origin].
    Chobanu LM
    Vopr Virusol; 1974; (1):87-9. PubMed ID: 4446552
    [No Abstract]   [Full Text] [Related]  

  • 26. Sialidase and protease activities of commercial (RDE) receptor destroying enzyme products used for the (HI) hemagglutination inhibition test of influenza viruses.
    Nakayama M; Ogawa Y; Yamazi Y
    Nihon Ika Daigaku Zasshi; 1986 Oct; 53(5):534-6. PubMed ID: 3536992
    [No Abstract]   [Full Text] [Related]  

  • 27. Structural analysis of the oligosaccharides of DR1 and DQw1 molecules.
    Iturbe S; Narasimhan S; Letarte M
    J Immunol; 1986 Jun; 136(12):4596-603. PubMed ID: 3486906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Castanospermine inhibits the processing of the oligosaccharide portion of the influenza viral hemagglutinin.
    Pan YT; Hori H; Saul R; Sanford BA; Molyneux RJ; Elbein AD
    Biochemistry; 1983 Aug; 22(16):3975-84. PubMed ID: 6615812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The behaviour of several influenza A2 virus strain neuraminidases after pronase treatment.
    Ionescu L; Handrache L; Alexandrescu M; Moroşanu V; Vancea G; Colev A
    Rev Roum Virol (1972); 1973; 10(3):209-12. PubMed ID: 4775622
    [No Abstract]   [Full Text] [Related]  

  • 30. Structures of the asparagine-linked sugar chains of laminin.
    Arumugham RG; Hsieh TC; Tanzer ML; Laine RA
    Biochim Biophys Acta; 1986 Aug; 883(1):112-26. PubMed ID: 3730425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attachment of influenza C virus to human erythrocytes.
    Nishimura H; Sugawara K; Kitame F; Nakamura K
    J Gen Virol; 1988 Oct; 69 ( Pt 10)():2545-53. PubMed ID: 3049938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of receptor sialoglycoprotein for hemagglutinating virus of Japan (Sendai virus) from bovine erythrocyte membrane.
    Suzuki Y; Suzuki T; Matsumoto M
    J Biochem; 1983 Jun; 93(6):1621-33. PubMed ID: 6309760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by kappa-casein glycomacropeptide and lactoferrin of influenza virus hemagglutination.
    Kawasaki Y; Isoda H; Shinmoto H; Tanimoto M; Dosako S; Idota T; Nakajima I
    Biosci Biotechnol Biochem; 1993 Jul; 57(7):1214-5. PubMed ID: 7763995
    [No Abstract]   [Full Text] [Related]  

  • 34. The glycoprotein of measles virus. External radioactive labelling of its carbohydrate and partial characterization of the glycopeptide.
    Anttonen O; Jokinen M; Salmi A; Vainionpää R; Gahmberg CG
    Biochem J; 1980 Jan; 185(1):189-94. PubMed ID: 7378046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of receptor destroying enzyme for removing non-specific serum inhibitors against recent influenza virus strains.
    Styk B
    Acta Virol; 1973 Sep; 17(5):446. PubMed ID: 4148123
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on host-virus interactions in the chick embryo-influenza virus system. IV. The role of inhibitors of hemagglutination in the evaluation of viral multiplication.
    LIU OC; HENLE W
    J Exp Med; 1951 Oct; 94(4):269-89. PubMed ID: 14888812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-combining oligosaccharides from a chick allantoic glycopeptide sulphate associated with influenza virus haemagglutinin.
    Higginbotham JD; Schöyen R; Mortensson-Egnund K; How MJ; Harboe A
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(3):349-56. PubMed ID: 4326439
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of influenza virus A 2 -Hongkong and A 2 -Asia].
    Frey WR
    Pathol Microbiol (Basel); 1972; 38(3):167-77. PubMed ID: 5065133
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation of a type A influenza virus from an Australian pelagic bird.
    Downie JC; Laver WG
    Virology; 1973 Feb; 51(2):259-69. PubMed ID: 4632652
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction of asparagine-linked oligosaccharides with an immobilized rice (Oryza sativa) lectin column.
    Poola I; Narasimhan S
    Biochem J; 1988 Feb; 250(1):117-24. PubMed ID: 3355507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.